Core Points - The document outlines the information disclosure deferral and exemption management system for Hangzhou Tianmu Mountain Pharmaceutical Co., Ltd, aiming to ensure compliance with legal obligations and protect investors' rights [1][2][3] Group 1: Information Disclosure Management - The company must adhere to various laws and regulations, including the Company Law and Securities Law, while managing information disclosure deferrals and exemptions [1] - Information that involves state secrets or commercial secrets must not be disclosed through any means, including investor interactions and press releases [2][3] - The company can defer or exempt disclosure of information that may lead to unfair competition or harm to its interests or those of others [3][4] Group 2: Conditions for Disclosure Deferral - If the reasons for deferral or exemption are no longer valid, or if the information becomes difficult to keep confidential, timely disclosure is required [5][6] - The definition of commercial secrets includes information that is not publicly known, provides economic benefits, and is protected by confidentiality measures [6][7] Group 3: Internal Review Procedures - A formal internal review process is required for deferring or exempting information disclosure, involving the board secretary and the company chairman [5][6] - The company must maintain records of all deferral and exemption requests for a minimum of 10 years [6] Group 4: Reporting Obligations - After the announcement of annual, semi-annual, or quarterly reports, the company must submit relevant documentation regarding deferred or exempted disclosures to the Zhejiang Securities Regulatory Bureau and the Shanghai Stock Exchange within ten days [6][7] - Any amendments to the system must comply with the latest laws and regulations, and the board is responsible for its formulation and revision [7]

Core Points - The company held its 16th meeting of the 10th Board of Directors on August 25, 2025, where all 11 directors participated, and the meeting complied with legal and regulatory requirements [1] - The Board approved the 2025 Half-Year Report and its summary with unanimous support [1] - The Board also approved the establishment of the "Information Disclosure Postponement and Exemption Management System" to enhance corporate governance [2] - The Board agreed to grant reserved stock options to the incentive objects under the 2024 Stock Option Incentive Plan, confirming that the conditions for granting have been met [2] Summary by Categories - **Meeting Details** - The meeting was held at the company's headquarters and included both in-person and video communication [1] - All 11 directors attended, and the meeting followed the required legal procedures [1] - **Financial Reporting** - The 2025 Half-Year Report was reviewed and approved with a vote of 11 in favor, indicating strong support from the Board [1] - **Corporate Governance** - The company developed a new management system for information disclosure postponement and exemption to improve operational standards [2] - **Incentive Plans** - The Board approved the granting of reserved stock options as part of the 2024 Stock Option Incentive Plan, confirming that the necessary conditions for granting were satisfied [2]

Core Points - Wu Tong Holdings Group Co., Ltd. held its 14th meeting of the 5th Board of Directors on August 25, 2025, with all 7 directors present, including independent directors voting via communication [1] - The board approved the 2025 semi-annual report, confirming it accurately reflects the company's situation without any false statements or omissions, with unanimous agreement from all board members [1] - The board also approved a special report on the use of raised funds for the first half of 2025, confirming compliance with regulations and proper use of funds without harming shareholder interests [2] - A new management system for information disclosure deferral and exemption was established to ensure compliance with disclosure obligations [3] Summary by Category Meeting Details - The meeting was convened in accordance with relevant laws and regulations, with all directors present and voting [1] Financial Reporting - The 2025 semi-annual report was deemed accurate and complete, receiving unanimous approval from the board [1] Fund Management - The special report on the use of raised funds confirmed compliance with regulations, with no misuse or changes in fund direction [2] Information Disclosure - A new system for managing information disclosure deferral and exemption was approved to ensure legal compliance [3]

General Principles - The company establishes a system for the temporary suspension and exemption of information disclosure to ensure compliance with legal obligations under relevant laws and regulations [1][2] - The system applies to the company and other information disclosure obligors, including directors, senior management, shareholders, and other related parties [1] Scope of Temporary Suspension and Exemption - Information can be temporarily suspended or exempted from disclosure if it involves state secrets or commercial secrets that could lead to unfair competition or harm to the company or others [2][3] - The company has an obligation to protect state secrets and must not disclose sensitive information through any means [2] Internal Review Procedures - The company’s board secretary is responsible for organizing and coordinating the temporary suspension and exemption of information disclosure, with the securities investment department assisting in daily operations [5] - Relevant departments must control the number of individuals aware of the information and require confidentiality agreements to prevent information leakage [5] Accountability - If the company or other obligors fail to comply with the disclosure regulations, they may face accountability for misleading statements or omissions, and responsible individuals may be held liable [6] Implementation - The system will be effective upon approval by the company's board of directors, and any amendments will be made in accordance with legal requirements [6]

Group 1 - The company did not distribute cash dividends, issue bonus shares, or increase capital from reserves during the reporting period [2] - The board of directors approved the asset impairment provision for the first half of 2025, which aligns with accounting standards and reflects the company's asset and financial status accurately [8][11] - The company plans to change its business registration type to align with new regulatory standards, from a joint-stock limited company to a limited company [15] Group 2 - The board meeting was held on August 21, 2025, with all seven directors present, ensuring compliance with legal and procedural requirements [8][10] - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period [4][5] - The company has established a system for managing information disclosure deferrals and exemptions to protect investors' rights [13]

Core Viewpoint - The article outlines the information disclosure deferral and exemption management system for Qingdao Huijin Tong Electric Equipment Co., Ltd, emphasizing the importance of protecting state secrets and ensuring compliance with relevant laws and regulations [2][5]. Group 1: Information Disclosure Management - The company and other obligated parties must fulfill their duty to protect state secrets and cannot disclose sensitive information through various channels [2][3]. - The system is established to regulate the deferral and exemption of information disclosure, protecting investors' rights and ensuring compliance with laws such as the Securities Law and the Stock Listing Rules [2][4]. - Information must be disclosed truthfully, accurately, completely, timely, and fairly, without abusing deferral or exemption to mislead investors or engage in illegal activities [2][4]. Group 2: Conditions for Deferral and Exemption - Deferral or exemption of disclosure is permitted if there is sufficient evidence that the information involves state secrets or could violate confidentiality regulations [2][5]. - Commercial secrets can be deferred or exempted from disclosure if they fall under specific conditions, such as core technology information that could lead to unfair competition [2][4]. - If the reasons for deferral or exemption are eliminated, the company must promptly disclose the information and provide justification for its classification as a commercial secret [2][4]. Group 3: Internal Procedures and Responsibilities - The chairman of the board is the primary responsible person for deferral and exemption matters, while the board secretary manages daily operations related to these issues [2][5]. - The company must maintain records of deferral and exemption actions, including reasons, internal review processes, and the status of insider trading during the deferral period [2][6]. - Any non-compliance with the established procedures may result in disciplinary actions against responsible personnel, in accordance with relevant laws and regulations [2][6].

Core Points - The document outlines the information disclosure deferral and exemption management system for Shaanxi Huaqin Technology Industrial Co., Ltd, aiming to ensure compliance with relevant laws and regulations [1][2] - The system emphasizes the importance of accurate, complete, and timely information disclosure while prohibiting the misuse of deferral or exemption to mislead investors [2][3] - It establishes internal review procedures for determining deferral and exemption matters, requiring documentation and approval from the board of directors [5][8] Group 1: General Principles - The purpose of the system is to regulate the deferral and exemption of information disclosure, ensuring compliance with the Securities Law and other relevant regulations [1] - Information disclosure obligors include the company, its directors, senior management, core technical personnel, shareholders, and other related parties [2] - The company must not abuse deferral or exemption to evade disclosure obligations or engage in insider trading [2][3] Group 2: Scope of Deferral and Exemption - Information can be deferred or exempted if it involves state secrets or other matters that may violate confidentiality regulations [3][4] - Commercial secrets can also be deferred or exempted if disclosure could lead to unfair competition or harm the interests of the company or others [4][5] - If the reasons for deferral or exemption are no longer valid, the company must disclose the information promptly [5][6] Group 3: Internal Review Procedures - The company must establish internal procedures for reviewing deferral and exemption requests, which must be approved by the board of directors [5][8] - The board secretary's office is responsible for organizing and coordinating the specific affairs related to deferral and exemption [6][7] - Documentation must be maintained for all deferral and exemption matters, including reasons for deferral and the internal review process [6][10] Group 4: Accountability and Compliance - The company has established a responsibility accountability mechanism for deferral and exemption practices, with potential penalties for non-compliance [7][9] - The system must align with the listing rules and other relevant regulations of the Shanghai Stock Exchange [9][10] - The board of directors is responsible for interpreting and revising the system as necessary [9][10]

General Principles - The company establishes a system for the deferral and exemption of information disclosure to regulate such behaviors and enhance information disclosure supervision, protecting investors' rights [1][2] - The system is based on various laws and regulations, including the Securities Law of the People's Republic of China and the Shenzhen Stock Exchange Listing Rules [1] Scope of Deferral and Exemption - The company and other obligated parties may defer or exempt disclosure if there is sufficient evidence that the information involves state secrets or could violate confidentiality regulations [2][3] - Obligated parties must not disclose state secrets through any form of communication, including investor interactions and press releases [2] - Information related to commercial secrets can be deferred or exempted if it meets specific criteria, such as potential harm to the company or others if disclosed [2][3] Internal Review Procedures - The internal review process for deferring or exempting disclosure includes submitting a registration form and confidentiality commitment to the securities affairs department [4][5] - The company must document the reasons for deferral or exemption, the type of information involved, and the internal review process [4][5] - Any deferred or exempted information must be disclosed promptly once the reasons for deferral are eliminated [3][4] Reporting Obligations - The company must report any deferred or exempted disclosures to the China Securities Regulatory Commission and the Shenzhen Stock Exchange within ten days after the announcement of periodic reports [5] - The company will hold individuals accountable for any violations of this system that lead to negative impacts or losses [5] Additional Provisions - The system must comply with the latest national laws and regulations, and any conflicting provisions will defer to the new regulations [6] - The board of directors is responsible for interpreting and amending this system [6]

Core Points - The company has revised certain corporate governance systems and established the "Information Disclosure Suspension and Exemption Management System" [1] - The revisions were approved during the 18th meeting of the 6th Board of Directors held on August 21, 2025 [1] - The changes aim to enhance the company's governance structure, optimize internal control systems, and promote standardized operations [1] Summary by Category Corporate Governance - The company has amended its governance systems in accordance with relevant laws and regulations, including the Company Law of the People's Republic of China and the Guidelines for Listed Companies [1] - The specific changes include renaming the "Management System for the Holding and Trading of Company Stocks by Directors, Supervisors, and Senior Management" to "Management System for the Holding and Trading of Company Stocks by Directors and Senior Management" [1] Information Disclosure - The newly established "Information Disclosure Suspension and Exemption Management System" is part of the company's efforts to improve its governance and compliance [1] - The full text of the revised and newly established systems has been published on the official information disclosure platform [1]

General Principles - The company establishes a system for the deferral and exemption of information disclosure to regulate the behavior of information disclosers and protect investors' rights [1][2] - Information disclosers must ensure that disclosures are truthful, accurate, complete, timely, and fair, and must not misuse deferral or exemption to evade disclosure obligations or mislead investors [1][2] Scope of Deferral and Exemption - Information can be deferred or exempted from disclosure if it involves state secrets or other matters that may violate confidentiality regulations [2][3] - Business secrets can be deferred or exempted if disclosure could lead to unfair competition, infringe on others' business secrets, or severely harm the interests of the company or others [2][3] Management of Deferral and Exemption - The board of directors is responsible for the unified leadership and management of deferral and exemption matters, with the board secretary coordinating these activities [4][5] - A specific approval process is outlined for deferral and exemption requests, including the completion of relevant forms and internal reviews [4][5] Accountability and Measures - The company will impose penalties on individuals responsible for non-compliance with the disclosure deferral and exemption system, including reporting violations to regulatory authorities [6] - The system will take effect upon approval by the board of directors, and any amendments will follow the same procedure [7]